Cascadian Therapeutics added to the Nasdaq Biotechnology Index
Cascadian Therapeutics announced that it has been selected for addition to the Nasdaq Biotechnology Index®. Cascadian Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative product candidates for the treatment of cancer. December 13, 2017